Rua Bioscience Limited logo

Announcement of Director Retirement & AGM Date

AGM7 August 2022RUAHealthcare

PO Box 1387, Gisborne 4040, Aotearoa New Zealand | 0800 RUABIO | www.ruabio.com




FOR PUBLIC RELEASE

NZX Limited

Wellington


Monday, 8 August 2022



Announcement of Director Retirement



The Board of Directors of Rua Bioscience Limited (NZX: RUA) advises that Mr Martin Smith has

decided to retire as an Independent Non-Executive Director. Martin’s retirement will be effective

at the conclusion of the 2022 Annual General Meeting scheduled for October 12, 2022.


Martin joined the Board of Directors in 2018 and is currently the Chair of the Nominations and

Remunerations Committee.


Rua’s Chair Mr Trevor Burt, on behalf of the Board, expresses his sincere appreciation of Martin’s

significant contribution to the company during his five-year tenure. Mr Burt said that ‘it is quite a

career milestone for Martin to join our founders when the business was at the conceptual stage,

and to be a key part of the governance team who guided the business through to a NZX listing

and readiness for export markets. We wish Martin all the best for his future.’


Martin Smith’s retirement is consistent with the Board’s succession plan and follows the recent

appointment of Teresa Farac-Ciprian as an Independent Non-Executive Director. Teresa brings

an exceptional background in commercialisation, innovation, marketing and business

development – skills particularly relevant as the company nears export market entry.


ENDS


For more information please contact:

Kerry Donovan

Communications Manager, Rua Bioscience Ltd

Kerry.donovan@ruabio.com

+64 (0)21 128 7689






ADMINISTRATIVE ANNOUNCEMENT

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.